Cecha
Big lower jaw
Nazwa kliniczna: Mandibular prognathia
Abnormal prominence of the chin related to increased length of the mandible.
Podsumowanie
- Znana także jako
- Increased projection of lower jaw, Increased size of lower jaw, Increased size of mandible, Large lower jaw, Prominent chin, Prominent lower jaw, Big mandible, Enlarged mandible, Enlargement of mandible, Hyperplasia of lower jaw, Increased projection of mandible, Large mandible, Lower jaw excess, Lower jaw hyperplasia, Macromandible, Mandible prognathism, Mandibular excess, Mandibular hyperplasia, Mandibular macrognathia, Mandibular prognathism, Prognathia, Prognathism, Prominent jaw, Prominent mandible, Relative mandibular prognathism
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Big lower jaw, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test226 genów powiązanych z Big lower jaw
Zmiany w tych genach powodują rzadkie choroby, w których występuje Big lower jaw. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ACANaggrecan | Zawsze | W 3 chorobach |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Zawsze | W 1 chorobie |
| AMOTL1angiomotin like 1 | Zawsze | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Zawsze | W 1 chorobie |
| ATP6V0A1ATPase H+ transporting V0 subunit a1 | Zawsze | W 1 chorobie |
| ATRXATRX chromatin remodeler | Zawsze | W 1 chorobie |
| CDH11cadherin 11 | Zawsze | W 2 chorobach |
| DDX59DEAD-box helicase 59 | Zawsze | W 1 chorobie |
| ESAMendothelial cell adhesion molecule | Zawsze | W 1 chorobie |
| GNB2G protein subunit beta 2 | Zawsze | W 1 chorobie |
| GPC3glypican 3 | Zawsze | W 2 chorobach |
| HERC1HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 | Zawsze | W 2 chorobach |
| HS6ST2heparan sulfate 6-O-sulfotransferase 2 | Zawsze | W 1 chorobie |
| IL6STinterleukin 6 cytokine family signal transducer | Zawsze | W 1 chorobie |
| MED16mediator complex subunit 16 | Zawsze | W 1 chorobie |
| MYOD1myogenic differentiation 1 | Zawsze | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Zawsze | W 1 chorobie |
| PRKG2protein kinase cGMP-dependent 2 | Zawsze | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Zawsze | W 2 chorobach |
| RNF113Aring finger protein 113A | Zawsze | W 1 chorobie |
| RNU2-2RNA, U2 small nuclear 2 | Zawsze | W 1 chorobie |
| RPL10ribosomal protein L10 | Zawsze | W 3 chorobach |
| SLC12A2solute carrier family 12 member 2 | Zawsze | W 1 chorobie |
| SLC35A2solute carrier family 35 member A2 | Zawsze | W 1 chorobie |
| SLC6A17solute carrier family 6 member 17 | Zawsze | W 2 chorobach |
| SMAD4SMAD family member 4 | Zawsze | W 2 chorobach |
| SOSTsclerostin | Zawsze | W 3 chorobach |
| TPRKBTP53RK binding protein | Zawsze | W 1 chorobie |
| UBAP2Lubiquitin associated protein 2 like | Zawsze | W 1 chorobie |
| AGAaspartylglucosaminidase | Bardzo często (80–99%) | W 1 chorobie |
| AIPAHR interacting HSP90 co-chaperone | Bardzo często (80–99%) | W 2 chorobach |
| GPC4glypican 4 | Bardzo często (80–99%) | W 1 chorobie |
| GPR101G protein-coupled receptor 101 | Bardzo często (80–99%) | W 1 chorobie |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Bardzo często (80–99%) | W 1 chorobie |
| LRP5LDL receptor related protein 5 | Bardzo często (80–99%) | W 2 chorobach |
| MEN1menin 1 | Bardzo często (80–99%) | W 1 chorobie |
| NHSNHS actin remodeling regulator | Bardzo często (80–99%) | W 1 chorobie |
| PAX3paired box 3 | Bardzo często (80–99%) | W 3 chorobach |
| SLC25A24solute carrier family 25 member 24 | Bardzo często (80–99%) | W 2 chorobach |
| ACTA1actin alpha 1, skeletal muscle | Często (30–79%) | W 1 chorobie |
Pokaż jeszcze 186 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ADAMTSL1ADAMTS like 1 | Często (30–79%) | W 1 chorobie |
| ADAMTSL4ADAMTS like 4 | Często (30–79%) | W 1 chorobie |
| AIMP2aminoacyl tRNA synthetase complex interacting multifunctional protein 2 | Często (30–79%) | W 1 chorobie |
| ANKHANKH inorganic pyrophosphate transport regulator | Często (30–79%) | W 1 chorobie |
| ANTXR1ANTXR cell adhesion molecule 1 | Często (30–79%) | W 1 chorobie |
| APCAPC regulator of Wnt signaling pathway | Często (30–79%) | W 1 chorobie |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Często (30–79%) | W 1 chorobie |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Często (30–79%) | W 1 chorobie |
| CSNK2Bcasein kinase 2 beta | Często (30–79%) | W 1 chorobie |
| DEAF1DEAF1 transcription factor | Często (30–79%) | W 1 chorobie |
| DOCK3dedicator of cytokinesis 3 | Często (30–79%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Często (30–79%) | W 1 chorobie |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Często (30–79%) | W 1 chorobie |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Często (30–79%) | W 1 chorobie |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Często (30–79%) | W 3 chorobach |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Często (30–79%) | W 3 chorobach |
| EXOSC5exosome component 5 | Często (30–79%) | W 1 chorobie |
| FBN1fibrillin 1 | Często (30–79%) | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 2 chorobach |
| FGFR2fibroblast growth factor receptor 2 | Często (30–79%) | W 6 chorobach |
| FMR1fragile X messenger ribonucleoprotein 1 | Często (30–79%) | W 2 chorobach |
| FOXG1forkhead box G1 | Często (30–79%) | W 1 chorobie |
| FOXP1forkhead box P1 | Często (30–79%) | W 1 chorobie |
| GJA1gap junction protein alpha 1 | Często (30–79%) | W 2 chorobach |
| IL11RAinterleukin 11 receptor subunit alpha | Często (30–79%) | W 1 chorobie |
| KAT5lysine acetyltransferase 5 | Często (30–79%) | W 1 chorobie |
| KAT6Alysine acetyltransferase 6A | Często (30–79%) | W 1 chorobie |
| KPTNkaptin, actin binding protein | Często (30–79%) | W 2 chorobach |
| MBD5methyl-CpG binding domain protein 5 | Często (30–79%) | W 1 chorobie |
| MED25mediator complex subunit 25 | Często (30–79%) | W 1 chorobie |
| MGAT2alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Często (30–79%) | W 1 chorobie |
| NFIXnuclear factor I X | Często (30–79%) | W 1 chorobie |
| OPHN1oligophrenin 1 | Często (30–79%) | W 2 chorobach |
| PCGF2polycomb group ring finger 2 | Często (30–79%) | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Często (30–79%) | W 3 chorobach |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PMM2phosphomannomutase 2 | Często (30–79%) | W 1 chorobie |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 1 chorobie |
| PQBP1polyglutamine binding protein 1 | Często (30–79%) | W 3 chorobach |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Często (30–79%) | W 2 chorobach |
| PTENphosphatase and tensin homolog | Często (30–79%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Często (30–79%) | W 2 chorobach |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 2 chorobach |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Często (30–79%) | W 1 chorobie |
| RUNX2RUNX family transcription factor 2 | Często (30–79%) | W 1 chorobie |
| RUSC2RUN and SH3 domain containing 2 | Często (30–79%) | W 1 chorobie |
| SFRP4secreted frizzled related protein 4 | Często (30–79%) | W 2 chorobach |
| SH3PXD2BSH3 and PX domains 2B | Często (30–79%) | W 1 chorobie |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 1 chorobie |
| STAT3signal transducer and activator of transcription 3 | Często (30–79%) | W 1 chorobie |
| STEEP1STING1 ER exit protein 1 | Często (30–79%) | W 1 chorobie |
| STT3ASTT3 oligosaccharyltransferase complex catalytic subunit A | Często (30–79%) | W 1 chorobie |
| SVILsupervillin | Często (30–79%) | W 1 chorobie |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Często (30–79%) | W 1 chorobie |
| ZEB2zinc finger E-box binding homeobox 2 | Często (30–79%) | W 2 chorobach |
| ACBD6acyl-CoA binding domain containing 6 | Czasami (5–29%) | W 1 chorobie |
| ACTBactin beta | Czasami (5–29%) | W 1 chorobie |
| AFF3ALF transcription elongation factor 3 | Czasami (5–29%) | W 1 chorobie |
| ATAD3AATPase family AAA domain containing 3A | Czasami (5–29%) | W 2 chorobach |
| ATP10AATPase phospholipid transporting 10A (putative) | Czasami (5–29%) | W 1 chorobie |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Czasami (5–29%) | W 1 chorobie |
| CDC42BPBCDC42 binding protein kinase beta | Czasami (5–29%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Czasami (5–29%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Czasami (5–29%) | W 1 chorobie |
| CLIC2CLIC family member 2 | Czasami (5–29%) | W 1 chorobie |
| CNOT3CCR4-NOT transcription complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| CRELD1CRELD disulfide isomerase 1 | Czasami (5–29%) | W 1 chorobie |
| CTCFCCCTC-binding factor | Czasami (5–29%) | W 1 chorobie |
| DHX30DExH-box helicase 30 | Czasami (5–29%) | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Czasami (5–29%) | W 1 chorobie |
| DOT1LDOT1 like histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| FAM20CFAM20C golgi associated secretory pathway kinase | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FBXW11F-box and WD repeat domain containing 11 | Czasami (5–29%) | W 1 chorobie |
| GORABgolgin, RAB6 interacting | Czasami (5–29%) | W 2 chorobach |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Czasami (5–29%) | W 1 chorobie |
| GRIA4glutamate ionotropic receptor AMPA type subunit 4 | Czasami (5–29%) | W 1 chorobie |
| H3-3BH3.3 histone B | Czasami (5–29%) | W 1 chorobie |
| H4C5H4 clustered histone 5 | Czasami (5–29%) | W 1 chorobie |
| HNF1BHNF1 homeobox B | Czasami (5–29%) | W 1 chorobie |
| HNRNPH1heterogeneous nuclear ribonucleoprotein H1 | Czasami (5–29%) | W 1 chorobie |
| INSRinsulin receptor | Czasami (5–29%) | W 2 chorobach |
| KCTD1potassium channel tetramerization domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| KDM5Clysine demethylase 5C | Czasami (5–29%) | W 1 chorobie |
| KDM6Blysine demethylase 6B | Czasami (5–29%) | W 1 chorobie |
| LTBP3latent transforming growth factor beta binding protein 3 | Czasami (5–29%) | W 1 chorobie |
| MAFMAF bZIP transcription factor | Czasami (5–29%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Czasami (5–29%) | W 2 chorobach |
| MED13Lmediator complex subunit 13L | Czasami (5–29%) | W 1 chorobie |
| MEG3maternally expressed 3 | Czasami (5–29%) | W 1 chorobie |
| MESDmesoderm development LRP chaperone | Czasami (5–29%) | W 1 chorobie |
| MYH7myosin heavy chain 7 | Czasami (5–29%) | W 1 chorobie |
| MYH8myosin heavy chain 8 | Czasami (5–29%) | W 1 chorobie |
| NDST1N-deacetylase and N-sulfotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| NEXMIFneurite extension and migration factor | Czasami (5–29%) | W 1 chorobie |
| NSRP1nuclear speckle splicing regulatory protein 1 | Czasami (5–29%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Czasami (5–29%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Czasami (5–29%) | W 1 chorobie |
| PCDHGC4protocadherin gamma subfamily C, 4 | Czasami (5–29%) | W 1 chorobie |
| PGAP2post-GPI attachment to proteins 2 | Czasami (5–29%) | W 1 chorobie |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Czasami (5–29%) | W 1 chorobie |
| PIGBphosphatidylinositol glycan anchor biosynthesis class B | Czasami (5–29%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Czasami (5–29%) | W 1 chorobie |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Czasami (5–29%) | W 1 chorobie |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Czasami (5–29%) | W 2 chorobach |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Czasami (5–29%) | W 1 chorobie |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Czasami (5–29%) | W 1 chorobie |
| PLAAT3phospholipase A and acyltransferase 3 | Czasami (5–29%) | W 1 chorobie |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Czasami (5–29%) | W 1 chorobie |
| PTCH1patched 1 | Czasami (5–29%) | W 2 chorobach |
| PTCH2patched 2 | Czasami (5–29%) | W 1 chorobie |
| PUF60poly(U) binding splicing factor 60 | Czasami (5–29%) | W 1 chorobie |
| PYCR1pyrroline-5-carboxylate reductase 1 | Czasami (5–29%) | W 1 chorobie |
| RFX7regulatory factor X7 | Czasami (5–29%) | W 1 chorobie |
| RNF125ring finger protein 125 | Czasami (5–29%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Czasami (5–29%) | W 1 chorobie |
| SELENONselenoprotein N | Czasami (5–29%) | W 1 chorobie |
| SLC10A7solute carrier family 10 member 7 | Czasami (5–29%) | W 1 chorobie |
| SLC35C1solute carrier family 35 member C1 | Czasami (5–29%) | W 1 chorobie |
| SLC4A10solute carrier family 4 member 10 | Czasami (5–29%) | W 1 chorobie |
| SLC6A1solute carrier family 6 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC6A11solute carrier family 6 member 11 | Czasami (5–29%) | W 1 chorobie |
| SMPD4sphingomyelin phosphodiesterase 4 | Czasami (5–29%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Czasami (5–29%) | W 1 chorobie |
| SUFUSUFU negative regulator of hedgehog signaling | Czasami (5–29%) | W 1 chorobie |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Czasami (5–29%) | W 1 chorobie |
| TBCKTBC1 domain containing kinase | Czasami (5–29%) | W 2 chorobach |
| TONSLtonsoku like, DNA repair protein | Czasami (5–29%) | W 2 chorobach |
| TTNtitin | Czasami (5–29%) | W 1 chorobie |
| UBE3Aubiquitin protein ligase E3A | Czasami (5–29%) | W 5 chorobach |
| WDR62WD repeat domain 62 | Czasami (5–29%) | W 1 chorobie |
| WDR83OSWD repeat domain 83 opposite strand | Czasami (5–29%) | W 1 chorobie |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Rzadko (1–4%) | W 1 chorobie |
| COL13A1collagen type XIII alpha 1 chain | Rzadko (1–4%) | W 1 chorobie |
| COLQcollagen like tail subunit of asymmetric acetylcholinesterase | Rzadko (1–4%) | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Rzadko (1–4%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Rzadko (1–4%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Rzadko (1–4%) | W 1 chorobie |
| H3-3AH3.3 histone A | Rzadko (1–4%) | W 1 chorobie |
| KIF7kinesin family member 7 | Rzadko (1–4%) | W 1 chorobie |
| LAMB2laminin subunit beta 2 | Rzadko (1–4%) | W 1 chorobie |
| SMSspermine synthase | Rzadko (1–4%) | W 2 chorobach |
| AGPAT21-acylglycerol-3-phosphate O-acyltransferase 2 | Nie odnotowano | W 1 chorobie |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Nie odnotowano | W 1 chorobie |
| AP4M1adaptor related protein complex 4 subunit mu 1 | Nie odnotowano | W 1 chorobie |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Nie odnotowano | W 1 chorobie |
| CHRNEcholinergic receptor nicotinic epsilon subunit | Nie odnotowano | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Nie odnotowano | W 1 chorobie |
| CUL4Bcullin 4B | Nie odnotowano | W 1 chorobie |
| CUL7cullin 7 | Nie odnotowano | W 1 chorobie |
| DYMdymeclin | Nie odnotowano | W 1 chorobie |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Nie odnotowano | W 1 chorobie |
| FLCNfolliculin | Nie odnotowano | W 1 chorobie |
| GALNSgalactosamine (N-acetyl)-6-sulfatase | Nie odnotowano | W 1 chorobie |
| GFPT1glutamine--fructose-6-phosphate transaminase 1 | Nie odnotowano | W 1 chorobie |
| GLB1galactosidase beta 1 | Nie odnotowano | W 1 chorobie |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Nie odnotowano | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Nie odnotowano | W 1 chorobie |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Nie odnotowano | W 1 chorobie |
| IDUAalpha-L-iduronidase | Nie odnotowano | W 1 chorobie |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Nie odnotowano | W 1 chorobie |
| KIF11kinesin family member 11 | Nie odnotowano | W 1 chorobie |
| LRP4LDL receptor related protein 4 | Nie odnotowano | W 1 chorobie |
| MAGEL2MAGE family member L2 | Nie odnotowano | W 1 chorobie |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Nie odnotowano | W 1 chorobie |
| MUSKmuscle associated receptor tyrosine kinase | Nie odnotowano | W 1 chorobie |
| MYH3myosin heavy chain 3 | Nie odnotowano | W 1 chorobie |
| POC1APOC1 centriolar protein A | Nie odnotowano | W 1 chorobie |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Nie odnotowano | W 1 chorobie |
| RECQL4RecQ like helicase 4 | Nie odnotowano | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Nie odnotowano | W 1 chorobie |
| SETD2SET domain containing 2, histone lysine methyltransferase | Nie odnotowano | W 1 chorobie |
| SLC6A8solute carrier family 6 member 8 | Nie odnotowano | W 1 chorobie |
| SLC9A6solute carrier family 9 member A6 | Nie odnotowano | W 1 chorobie |
| SOX18SRY-box transcription factor 18 | Nie odnotowano | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Nie odnotowano | W 1 chorobie |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Nie odnotowano | W 1 chorobie |
| TBC1D7TBC1 domain family member 7 | Nie odnotowano | W 1 chorobie |
| TGFB1transforming growth factor beta 1 | Nie odnotowano | W 1 chorobie |
| THUMPD1THUMP domain 1 NAT10 acetyltransferase adaptor | Nie odnotowano | W 1 chorobie |
| TNFSF11TNF superfamily member 11 | Nie odnotowano | W 1 chorobie |
| TNNI2troponin I2, fast skeletal type | Nie odnotowano | W 1 chorobie |
| TWIST2twist family bHLH transcription factor 2 | Nie odnotowano | W 1 chorobie |
| TXNL4Athioredoxin like 4A | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni